Chongqing, Chongqing Shi, China Boyi Fund is the famous VC, which was founded in 2014. The fund was located in Asia if to be more exact in China. The main department of described VC is located in the Chongqing Shi.
Among the most popular fund investment industries, there are Biotechnology, Chemical. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight Hunan HuaTeng Pharmaceutical Co., Ltd..
The typical case for the fund is to invest in rounds with 3 participants. The meaningful sponsors for the fund in investment in the same round are Zhudan Equity Investment Fund, Dingteng Juzhi Investment.
The important activity for fund was in 2019. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 5 - 10 millions dollars.
Related Funds
| Fund Name | Location |
| Emerisque Ventures | - |
| I-SHIN | - |
| Integrated Capital | China, Hong Kong, Hong Kong Island |
| ISB Ventures | California, San Francisco, United States |
| Marciano Investment Group, LLC | - |
| Mitsui Private Equity | New York, New York, United States |
| Richmont Capital Partners | Dallas, Texas, United States |
| SWS Venture Capital | Florida, Naples, United States |
| The Beall Family Trust | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Ractigen Therapeutics | $17M | 18 Feb 2021 | Nantong, Jiangsu, China | ||
Hunan HuaTeng Pharmaceutical Co., Ltd. | $7M | 27 Sep 2019 | China, Wuwei, China | ||
| $1M | 25 Jul 2017 | China, Shanghai | |||
Chongqing Shangyao Huiyuan Yaoye Youxian Gongsi | $3M | 17 Oct 2016 | Yubei District, Chongqing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Ractigen Therapeutics | $17M | 18 Feb 2021 | Nantong, Jiangsu, China | ||
Hunan HuaTeng Pharmaceutical Co., Ltd. | $7M | 27 Sep 2019 | China, Wuwei, China | ||
| $1M | 25 Jul 2017 | China, Shanghai | |||
Chongqing Shangyao Huiyuan Yaoye Youxian Gongsi | $3M | 17 Oct 2016 | Yubei District, Chongqing, China |
